HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LeFever, G B Articles by Morrow, A L Search for Related Content PubMed PubMed Citation Articles by LeFever, G B Articles by Morrow, A L

The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools.

G B LeFever, K V Dawson and A L Morrow

Center for Pediatric Research, Children's Hospital of The King's Daughters, Eastern Virginia Medical School, Norfolk, USA. glefever@chkd.com

OBJECTIVES: The purpose of this study was to determine the extent of medication use for attention deficit-hyperactivity disorder (ADHD) in southeastern Virginia. METHODS: Students enrolled in grades 2 through 5 in school districts in city A (n = 5767 students) and city B (n = 23,967 students) were included. Nurses recorded students who received ADHD medication in school. RESULTS: The proportion of students receiving ADHD medication was similar in both cities (8% and 10%) and was 2 to 3 times as high as the expected rate of ADHD. Receipt of drug therapy was associated with social and educational characteristics. Medication was used by 3 times as many boys as girls and by twice as many Whites as Blacks. Medication use increased with years in school, and by fifth grade 18% to 20% of White boys were receiving ADHD medication. Being young for one's grade was positively associated with medication use (P < .01). The prevalence of ADHD was 12% in district A, 63% in district B. CONCLUSIONS: These findings suggest that criteria for diagnosis of ADHD vary substantially across US populations, with potential overdiagnosis and overtreatment of ADHD in some groups of children.

This article has been cited by other articles:

				H. Hervey-Jumper, K. Douyon, T. Falcone, and K. N. Franco Identifying, Evaluating, Diagnosing, and Treating ADHD in Minority Youth J Atten Disord, March 1, 2008; 11(5): 522 - 528. [Abstract] [PDF]

				M. J. Sciutto and M. Eisenberg Evaluating the Evidence For and Against the Overdiagnosis of ADHD J Atten Disord, September 1, 2007; 11(2): 106 - 113. [Abstract] [PDF]

				L. A. Strohschein Prevalence of methylphenidate use among Canadian children following parental divorce Can. Med. Assoc. J., June 5, 2007; 176(12): 1711 - 1714. [Abstract] [Full Text] [PDF]

				P. J. Landrigan, L. Trasande, L. E. Thorpe, C. Gwynn, P. J. Lioy, M. E. D'Alton, H. S. Lipkind, J. Swanson, P. D. Wadhwa, E. B. Clark, et al. The National Children's Study: A 21-Year Prospective Study of 100 000 American Children Pediatrics, November 1, 2006; 118(5): 2173 - 2186. [Abstract] [Full Text] [PDF]

				C. E. Perry, D. Hatton, and J. Kendall Latino Parents' Accounts of Attention Deficit Hyperactivity Disorder J Transcult Nurs, October 1, 2005; 16(4): 312 - 321. [Abstract] [PDF]

				J. Kendall, M. C. Leo, N. Perrin, and D. Hatton Service Needs of Families With Children With ADHD Journal of Family Nursing, August 1, 2005; 11(3): 264 - 288. [Abstract] [PDF]

				J. A. Dopheide ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients Am. J. Health Syst. Pharm., July 15, 2005; 62(14): 1502 - 1509. [Full Text] [PDF]

				J. Kendall, M. C. Leo, N. Perrin, and D. Hatton Modeling ADHD Child and Family Relationships West J Nurs Res, June 1, 2005; 27(4): 500 - 518. [Abstract] [PDF]

				J. Lenzer Researcher to be sacked after reporting high rates of ADHD BMJ, March 26, 2005; 330(7493): 691. [Full Text]

				F. D. Butterfoss, C. Kelly, and J. Taylor-Fishwick Health Planning That Magnifies the Community's Voice: Allies Against Asthma Health Educ Behav, February 1, 2005; 32(1): 113 - 128. [Abstract] [PDF]

				M. D. Rappley Attention Deficit-Hyperactivity Disorder N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173. [Full Text] [PDF]

				D. S. Mandell, W. W. Thompson, E. S. Weintraub, F. DeStefano, and M. B. Blank Trends in Diagnosis Rates for Autism and ADHD at Hospital Discharge in the Context of Other Psychiatric Diagnoses Psychiatr Serv, January 1, 2005; 56(1): 56 - 62. [Abstract] [Full Text] [PDF]

				L. L. Greenhill, S. Pliszka, M. K. Dulcan, W. Bernet, V. Arnold, J. Beitchman, R. S. Benson, O. Bukstein, J. Kinlan, J. McClellan, et al. Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults Focus, October 1, 2004; 2(4): 642 - 668. [Abstract] [Full Text] [PDF]

				S. dosReis, P. L. Owens, K. B. Puccia, and P. J. Leaf Multimodal Treatment for ADHD Among Youths in Three Medicaid Subgroups: Disabled, Foster Care, and Low Income Psychiatr Serv, September 1, 2004; 55(9): 1041 - 1048. [Abstract] [Full Text] [PDF]

				L. Sax and K. J. Kautz Who First Suggests the Diagnosis of Attention-Deficit/Hyperactivity Disorder? Ann. Fam. Med, September 1, 2003; 1(3): 171 - 174. [Abstract] [Full Text] [PDF]

				J. Kendall and K. Shelton A Typology of Management Styles in Families with Children with ADHD Journal of Family Nursing, August 1, 2003; 9(3): 257 - 280. [Abstract] [PDF]

				E. H. Harel and W. D. Brown Attention Deficit Hyperactivity Disorder in Elementary School Children in Rhode Island: Associated Psychosocial Factors and Medications Used Clinical Pediatrics, July 1, 2003; 42(6): 497 - 503. [Abstract] [PDF]

				C. A. Lesesne, S. N. Visser, and C. P. White Attention-Deficit/Hyperactivity Disorder in School-Aged Children: Association With Maternal Mental Health and Use of Health Care Resources Pediatrics, May 1, 2003; 111(5): 1232 - 1237. [Abstract] [Full Text] [PDF]

				J. M. REY and M. G. SAWYER Are psychostimulant drugs being used appropriately to treat child and adolescent disorders? The British Journal of Psychiatry, April 1, 2003; 182(4): 284 - 286. [Full Text] [PDF]

				E. R. Cox, B. R. Motheral, R. R. Henderson, and D. Mager Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample Pediatrics, February 1, 2003; 111(2): 237 - 243. [Abstract] [Full Text] [PDF]

				J. C. Brehaut, A. Miller, P. Raina, and K. M. McGrail Childhood Behavior Disorders and Injuries Among Children and Youth: A Population-Based Study Pediatrics, February 1, 2003; 111(2): 262 - 269. [Abstract] [Full Text] [PDF]

				V. E. Snider, T. Busch, and L. Arrowood Teacher Knowledge of Stimulant Medication and ADHD Remedial and Special Education, January 1, 2003; 24(1): 46 - 56. [Abstract] [PDF]

				J. M. Zito, D. J. Safer, S. dosReis, J. F. Gardner, L. Magder, K. Soeken, M. Boles, F. Lynch, and M. A. Riddle Psychotropic Practice Patterns for Youth: A 10-Year Perspective Arch Pediatr Adolesc Med, January 1, 2003; 157(1): 17 - 25. [Abstract] [Full Text] [PDF]

				R. A. Barkley, M. Fischer, L. Smallish, and K. Fletcher Does the Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants Contribute to Drug Use/Abuse? A 13-Year Prospective Study Pediatrics, January 1, 2003; 111(1): 97 - 109. [Abstract] [Full Text] [PDF]

				C. Poulin Adolescent stimulant use Can. Med. Assoc. J., July 1, 2002; 167(1): 15 - 16. [Full Text] [PDF]

				J. Guevara, P. Lozano, T. Wickizer, L. Mell, and H. Gephart Psychotropic Medication Use in a Population of Children Who Have Attention-Deficit/Hyperactivity Disorder Pediatrics, May 1, 2002; 109(5): 733 - 739. [Abstract] [Full Text] [PDF]

				A. S. Rowland, D. M. Umbach, L. Stallone, A. J. Naftel, E. M. Bohlig, and D. P. Sandler Prevalence of Medication Treatment for Attention Deficit-Hyperactivity Disorder Among Elementary School Children in Johnston County, North Carolina Am J Public Health, February 1, 2002; 92(2): 231 - 234. [Abstract] [Full Text] [PDF]

				J. Lundholm-Brown and M. E. Dildy Attention-Deficit/Hyperactivity Disorder: An Educational Cultural Model The Journal of School Nursing, December 1, 2001; 17(6): 307 - 315. [Abstract] [PDF]

				A. R. Miller, C. E. Lalonde, K. M. McGrail, and R. W. Armstrong Prescription of methylphenidate to children and youth, 1990-1996 Can. Med. Assoc. J., November 1, 2001; 165(11): 1489 - 1494. [Abstract] [Full Text] [PDF]

				C. Poulin Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use Can. Med. Assoc. J., October 1, 2001; 165(8): 1039 - 1044. [Abstract] [Full Text] [PDF]

				S. Goldstein and D. Turner The extent of drug therapy for ADHD among children in a large public school district J Atten Disord, April 1, 2001; 4(4): 212 - 219. [Abstract] [PDF]

				D. J. Safer and M. Malever Stimulant Treatment in Maryland Public Schools Pediatrics, September 1, 2000; 106(3): 533 - 539. [Abstract] [Full Text]

				ADHD: Unanswered Questions and Controversies Journal Watch Psychiatry, November 1, 1999; 1999(1101): 17 - 17. [Full Text]